At Beijing Puhua International Hospital, world leading cancer therapies are combined with natural therapies to aid in the fight against Cancer and help maintain the quality of your life.
Multi-disciplinary Therapies are used in the fight against Cancer
-Beijing Puhua International Hospital (BPIH) offers the world’s most advanced protocols and technologies in the successful treatment of cancer. This unique approach combines the latest science with Traditional Chinese Medicine, to help boost the body’s immune system to fight the disease and to maintain your quality of life.
Our advantage is:
An experienced team of multi-disciplinary experts
Personalized, comprehensive treatment plans
Pro- reactive and adaptive treatment protocols to fit different stages of malignancies
Minimize possible side effects by utilizing Natural Medicine
Patients leave with an improved quality of life
Therapies Available in Puhua
By using Ultrasound and CT technology, we are able to directly insert heat generating needles into the core of the cancer site. The area is then heated and once it exceeds 60℃, a systematic breakdown of proteins in the cancer cells will occur, degenerating them to the point that they become harmless.
Cryosurgical Ablation (CSA)
Using imaging guided techniques (Ultrasound, CT or MRI), cryo-probes are inserted into tumors to lower the temperature of the targeted area -160℃ or lower. Following this the emperature is then raised to the levels of 20 to 40.℃. This process is repeated two or three times, resulting in complete ablation of the tumor.
CSA has the following advantages:
• It is applicable to both small and large tumors. It can be used for ablation of single or multiple tumors.
• Cryosurgical ablation will not cause damage to large blood vessels and trachea, so it can be used to treat tumors near those areas.
• It is a painless operation, and it helps reduces pain caused by cancer.
• The whole process of cryosurgical ablation can be monitored through imaging techniques such as ultrasound, CT or MRI.
• After cancerous cells are destroyed by CSA, dead cancerous cells will release antigens which will stimulate the immune system to eradicate any remaining cancerous cells and reduce re-occurrence of cancer.
Cancer Microvascular Intervention (CMI)
By inserting a catheter into target arteries and injecting embolic material, chemotherapy agents or traditional Chinese medicine; we are able to reduce the blood flow to the cancer cells which leads to a shortage of oxygen in the cancer cells, resulting in tumor necrosis and destruction. By doing this we are able to successfully starve the tumor of oxygen.
It is also known as Irreversible Electroporation (IRE). It is a no thermal soft tissue ablation technique, using ultra short but strong electrical fields to create permanent and hence lethal nanopores in the cell membrane, to disrupt the cellular homeostasis and causing cell death.
Nanoknife Therapy can be applied to treat tumors in solid organs such as pancreas, liver, lung, kidney and the prostate. It is especially suitable for tumors adjacent to pancreas, hepatic hilar region, gallbladder, bile duct and ureters.
Photodynamic Therapy (PDT)
(sometimes called photo-chemotherapy), is a form of phototherapy using nontoxic light-sensitive compounds that are exposed to selective wavelengths of light, whereupon they become activated and toxic to targeted malignant and other targeted tissues. PDT has been proven to kill bacteria, fungi and viruses, and gained popularity in the treatment of acne.
It is used clinically to treat a wide range of medical conditions, including wet age-related macular degeneration (AMD) and malignant cancers, and is recognized as an effective and selective treatment strategy that is both minimally invasive and minimally toxic.
Immunotherapy (DC-CIK therapy)
CIK therapy (cytokine-induced killer cells): CIK cells are cytotoxic T-Cells that can seek and kill tumor cells. The number of CIK cells existing in body is very small and are not sufficient in number to combat cancer. In CIK therapy, CIK cells are isolated, amplified by at least 1,000 times and then re-infused into the patient’s body.
Experiments show that the cooling capacity of tumor cells are much lower than that of normal cells. When the temperature reaches 42.5 ℃ for a duration of more than 30 minutes, tumor cells will rapidly heat up, leading to their degeneration and destruction. Healthy cells on the other hand, do avoid damage due to their unique ability to stay cool. Thermotron-RF8 is Japan’s newest developed in hyperthermia machines. It can accurately target the position of the tumor and perform hyperthermia.
While it reduces tumor volume and relieves cancer pain, it does prevent the recurrence of cancer and even enhance the effects of other cancer therapies.
PD-1 is a checkpoint protein on immune cells called T cells. It normally acts as a type of “off switch” that helps keep the T cells from attacking other cells in the body. It does this when it attaches to PD-L1, a protein on some normal (and cancer) cells. When PD-1 binds to PD-L1, it basically tells the T cell to leave the other cell alone. Some cancer cells have large amounts of PD-L1, which helps them evade immune attack.
Monoclonal antibodies that target either PD-1 or PD-L1 can block this binding and boost the immune response against cancer cells. These PD-1 and PD-L1 inhibitors have significant effect in a variety of cancer treatment.
Traditional Chinese Medicine (TCM)
TCM is a safe and effective supportive treatment option used in conjunction with the above mentioned treatment modalities. Many Chinese herbs have strong immune-enhancing effects and can both enhance the effects of chemotherapy, radiation therapy, surgery and other modalities; while reducing toxicity and many normally experienced side-effects.
Traditional Chinese herbs can be given orally, by IV infusion, or injected to the tumor via blood vessels, with the help of DSA (digital subtraction angiography) guidance.
Multiple Discipline Medical Team
Dr. Xue Zhongqi—Director of Oncology, Chief Oncology Surgeon
Dr. Xue brings to the team at Beijing Puhua International Hospital the results of more than thirty (30) successful years of clinical experience, as one of China’s leading cancer surgeons. He is a leading expert and authority in the diagnosis and treatment of various cancers. Dr. Xue is renowned for his work in breast cancer, especially in the areas of mastectomy and breast reconstruction.
Dr. Xue has conducted in-depth research and clinical studies in the areas of: colorectal cancer, sarcoma, liver cancer and cancer of the kidney. He has published more than twenty (20) major academic papers and articles (both basic research and clinical) on these clinical areas. Many of these publications have earned a variety of meritorious awards.
Dr. Zhao Yuliang—Associate Director of Oncology, Chief Oncologist
Dr. Zhao has an unmatched level of experience, training and
knowledge regarding the clinical management of oncology patients and the clinical management and treatment of complicated cancer cases.
Dr. Zhao is extremely competent in minimizing side-effects, normally experienced from chemotherapy. Endeavoring always to do his best in providing comfort to his chemotherapy patients, while at the same time striving to achieve the best possible outcome, Dr. Zhao has become a leading advocate of developing a comprehensive and individual patient focused treatment plan, for every one of his patients.
Dr. Zhao works in the integrated oncology program at Beijing Puhua International Hospital, where he works in a team with Surgical Oncology, Traditional Chinese Medicine, and Cellular Immune-Therapy to optimize each patient’s clinical outcome.
Dr. Weijian Feng- Director of Minimally Invasive Therapy (MIT) Center
He is a Minimally Invasive Therapy (MIT) expert and Chief Physician, who has engaged in clinical tumor work as well as in tumor research for 25 years He has edited and compiled 12 monographs and over 90 research papers. As for his tumor therapies, he promotes a natural, minimal invasive and targeted therapy concept. His expertise lies in minimal invasive targeted therapy such as in situ inactivation for both lung and liver cancer. He is the inventor of percutaneous injection of hydrochloric acid Therapy in liver cancer patients.
Dr. Feng is well known for having carried out the highest number of radiofrequency ablations at our hospital, as well as for only using local chemotherapy for tumor volume reduction, used during the Middle and Late stages of cancer, providing high curative effects while reducing many possible side effects.
Dr. WeiRan Tang — Director of the Tumor Immunotherapy Center
Member, Jury of National Natural Science Foundation of China (NSFC)
Dr. Wang graduated from Heilongjiang University of Chinese Medicine, and later earned his PhD degree in Hokkaido University. He has published many academic articles in the area of immunotherapy.
Dr. Tang worked as a Chief Researcher at Genox Pharmaceutical Research Institute, and the National Center for Child Health and Development, while in Japan (1999-2005). Afterwards (2005-2011), he was a Deputy Professor in the Institute of Medicinal Biotechnology (IMB) of the Chinese Academy of Medical Sciences. His work has been focused on: the study of auto-immunological diseases; the identification of molecular targets; establishing high throughput drug screening models, and discovering optimal applications and prospects for bioactive drugs and agents.
Dr. Xuemei Liu- TCM expert
Graduated from Chengdu University of Traditional Chinese Medicine, Dr. Xuemei Liu is a student of several highly respected TCM Specialists. She has gain valuable experience by working in Sichuan Hospitals of TCM for 12 years. During her studies in the United States of America, she was awarded the American National Acupuncture and TCM Certificate and License of Acupuncture and TCM in California and New York. She has been working on both scientific research and clinical practice of TCM for a long period of time. Her clinical proficiency in both Acupuncture and Integrated Chinese and Western Medicine, along with her extensive clinical experience has resulted in significant contributions to the overseas development of TCM.
Her specialization in the areas of: TCM treatment for post-surgery, cancer, neurological diseases, digestive system diseases, chronic pain, breast diseases, gynecological diseases; won Dr. Tang the prestigious Award of the National Natural Science Foundation of China in 2008.
Online Inquiry–start your Free Medical Evaluation by filling the following form
Neurofibromatectomy, plastic surgery
Localized hepatic Intra-arterial Chemotherapy + hyperthermia + immune therapy + Traditional Chinese Medicine treatment
Optimized Chemotherapy, DC-CIK celluar therapy, Traditional Chinese Medicine.
Combined TCM therapy.
Combined TCM therapy.
Lesion resection in the vertebral canal via posterior middle approach.
DC-CIK Immunotherapy and Traditional Chinese Medicine (TCM)
Sono-dynamic therapy, DC-CIK celluar therapy, traditional Chinese medicine
Radio-Frequency Ablation (RFA); systemic chemotherapy, DC-CIK celluar therapy, traditional Chinese medicine (TCM)
PD-1 immunotherapy; Traditional Chinese Medicine
Intra-arterial chemotherapy, CIK immune therapy, Hyperthermia, Traditional Chinese Medicine